LEUKINE® (sargramostim) is the first and only FDA-approved GM-CSF1
GM-CSF=granulocyte-macrophage colony-stimulating factor.
The unique multipotent biology of LEUKINE stimulates multiple immune cell types1
LEUKINE efficacy has been demonstrated in a range of therapeutic settings for patients with hematologic malignancies1
